Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United ...

Republicans are aiming for major reductions in federal spending, and Medicaid seems a likely target. But the politics of ...

One particular application of AI on the rise at City of Hope is the development of a large language model (LLM) made ...

The end of federal diversity, equity and inclusion programs in the federal government may have a ripple effect on social ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...

A new article argues dystrophin immunogenicity is an under-examined issue in the treatment of Duchenne muscular dystrophy.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Bkemv is being offered at 10% off Soliris, and Epysqli is offered at 30% below Soliris. Both biosimilars treat several of the ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

Researchers found that use of immunosuppressive medication was a strong protective factor, associated with a 60% reduction in ...

Lexeo Therapeutics’ gene therapy provides a healthy version of the frataxin gene, which is critical for energy production in ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...